Monoclonal antibody in destruction of small cell lung carcinoma

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds specifically-identified oligosaccharide structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241331, 4241741, 4241811, 4241551, 5303888, 53038885, 5303873, A61K 39395, C07K 1618, C07K 1630

Patent

active

055230857

ABSTRACT:
Monoclonal antibody BR55-2 and fragments thereof having the specificity of monoclonal antibody BR55-2, and variants thereof, are useful in the treatment of small cell lung carcinoma.

REFERENCES:
Thom et al, Biochem J., vol. 168, pp. 187-194 (1977).
Laemmli, Nature, vol. 227, pp. 680-685 (1970).
Wilson et al, Immunofluorescence and Related Staining Techniques, Knapp et al--editors, pp. 215-224 (1978).
Colvin, Diagnotic Immunopathology, Raven Press, New York, pp. 437-452 (1988).
Steplewski, Z. et al., Hybridoma, vol. 9(2):201-210, 1990.
Scholz, D. et al., Cancer Immunol Immunother, 33:153-157, 1991.
Waldmann, T., Science, 252:1657-1662, 21 Jun. 1991.
Osband, M. E. et al., Immunology Today, 11(6):193-195, 1990.
Kannagi, R. et al, Handbook of Exp. Immunol, 4:117.1-117.20, May 30, 1986.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibody in destruction of small cell lung carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibody in destruction of small cell lung carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody in destruction of small cell lung carcinoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-381726

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.